8 research outputs found
Per una storia delle abbreviature latine
No full textGiove Marchioli Nicoletta. Per una storia delle abbreviature latine. In: Gazette du livre médiéval, n°18. Printemps 1991. pp. 17-24
I manoscritti datati della Biblioteca Queriniana di Brescia
No full textSi tratta del volume 18 della collana "Manoscritti datati d'Italia", che nasce dalla collaborazione fra docenti universitari, bibliotecari e ricercatori, riuniti nell'Associazione Italiana Manoscritti Datati (AIMD), tutti da tempo attivi nel campo della descrizione scientifica del manoscritto e nella riflessione su finalità e funzioni della catalogazione. Il volume contiene le descrizioni di 77 manoscritti datati conservati nella Biblioteca Queriniana di Brescia, ed è corredato dai contributi sulla storia della biblioteca, dagli indici e dalla bibliografia generale
La miniatura nei Manoscritti di Rovigo e di Adria
No full textNel saggio vengono presentati i manoscritti miniati della Biblioteca dei Concordi di Rovigo e di quella di Adria. Si tratta di illustrazioni del XIV e del XV secolo di ambito bolognese, veneto e ferrarese. Spiccano per importanza i frammenti di Bibbia Atlantica, miniati in primo stile geometrico in Italia centrale, alcune opere di miniatori bolognesi tra cui un inedito di Stefano degli Azzi, nonché la Bibbia Istoriata Padovana opera eseguita da una bottega di miniatori attiva a Padova allo scadere del Trecento che la critica ha già giustamente avvicinato alla cultura figurativa di ambito neo giottesco e in particolare a Altichiero e a Giusto de' Menabuoi. Tra i manoscritti di Adria vi sono due interessanti esemplari di ornato umanistico a bianchi girari, di cui uno è certamente riconducibile a Ferrara e in particolare ai codici miniati per Ercole I d'Este
I manoscritti medievali di Vicenza e Provincia
No full textL'opera cataloga i manoscritti medievali della Biblioteca Bertoliana e delle biblioteche della provincia di Vicenza. Federica Toniolo ha visionato tutti i codici miniati ed è responsabile delle attribuzioni ad ambiti a scuole e maestri
Pelerinage: Dataset
No full textThe "Pelerinage" dataset contains a fine-grained edition of excerpts from 20 medieval manuscripts of Guillaume de Digulleville's Pelerinage de vie humaine.
Files in this directory were created as part of the ECMEN Ecritures médiévales et outils numériques research project, funded by the City of Paris in the Emergence(s) framework.
If you use any of the following files, please quote:
Stutzmann, Dominique. « Les 'manuscrits datés', base de données sur l’écriture ». In Catalogazione, storia della scrittura, storia del libro. I Manoscritti datati d’Italia vent’anni dopo, ed. Teresa De Robertis and Nicoletta Giovè Marchioli, Firenze: SISMEL - Edizioni del Galluzzo, 2017, p. 155-207.
@incollection{stutzmann_les_2017,
address = {Firenze},
title = {Les « manuscrits datés », base de données sur l’écriture},
language = {fre},
booktitle = {Catalogazione, storia della scrittura, storia del libro. {I} {Manoscritti} datati d’{Italia} vent’anni dopo},
publisher = {SISMEL - Edizioni del Galluzzo},
author = {Stutzmann, Dominique},
editor = {De Robertis, Teresa and Giovè Marchioli, Nicoletta},
year = {2017},
pages = {155--207}
}
SOURCE DESCRIPTION
The source of the files are imitative transcriptions of selected passages by Géraldine Veysseyre (ORCID 0000-0002-3737-2137) based on 20 medieval manuscripts containing the "Pelerinage de vie humaine" of Guillaume de Digulleville, as produced during the OPVS research project (the acronym stands for « Old Pious Vernacular Successes » in English and « Œuvres Pieuses Vernaculaires à Succès » in French), funded by the ERC under the grant agreement n° 263274).
The transcriptions were edited and enhanced in TEI format by Dominique Stutzmann (ORCID 0000-0003-3705-5825) and Floriana Ceresato (IRHT-CNRS), as part of the ORIFLAMMS and the ECMEN (Ecritures médiévales et outils numériques) research project with following features:
semantic encoding (, , , )
, , etc. and entities to describe abbreviations
minimal description of manuscripts
Links to images and coordinates to pixels of the image for each line were added by Floriana Ceresato and Alexandre Gaudin (IRHT-CNRS).
Files in ALTO format were produced in 2021 by Jean-Baptiste Camps (ORCID 0000-0003-0385-7037) and Chahan Vidal-Gorène (ORCID 0000-0003-1567-6508) as part of a joint research presented at the conference DH2022 (Tokyo, 25-29 July 2022), cf. (abstract)
Camps, Jean-Baptiste, Chahan Vidal-Gorène, Dominique Stutzmann, Marguerite Vernet, and Ariane Pinche. « Data Diversity in Handwritten Text Recognition: Challenge or Opportunity? » In Digital Humanities 2022. Conference Abstracts (The University of Tokyo, Japan, 25-29 July 2022), published by DH2022 Local Organizing Committee, 160‑65. Tokyo, 2022. https://dh2022.dhii.asia/dh2022bookofabsts.pdf#page=162 and https://dh2022.dhii.asia/abstracts/files/CAMPS_Jean_Baptiste_Data_Diversity_in_handwritten_text_recog.html.
The dataset comprises the following folders:
/texts/ : main TEI file containing all textual, semantic and graphic information.
/img/ : 49 images on which the transcriptions are based and to which they are aligned at line level through the element in the TEI file.
/alto/ : one file per image in Alto format in several flavours according to the needs of the users during the experiments of the above mentioned paper. The text is flat, line by line, either with expansion or with abbreviations, and either with standardisation or according to the original encoding. Given the current implementation of Kraken/eScriptorium, coordinates may be indicated as "x1,y1 x2,y2..." in "/alto/without-norm-coord-commas/" but as "x1 y1 x2 y2..." in the other folders.
/img-masks/ : smaller images with a view of all coordinates of lines as present in the TEI > facsimile elements, including lines which were not selected for the transcription
Current applications of therapeutic phlebotomy
No full text[No abstract available]Aarsand AK, 2009, CLIN CHEM, V55, P795, DOI 10.1373-clinchem.2008.117432; Adams PC, 2010, BLOOD, V116, P317, DOI 10.1182-blood-2010-01-261875; Ahmad KA, 2002, BLOOD CELL MOL DIS, V29, P361, DOI 10.1006-bcmd.2002.0575; Andersen RV, 2004, BLOOD, V103, P2914, DOI 10.1182-blood-2003-10-3564; [Anonymous], 1997, BR J HAEMATOL, V97, P453; [Anonymous], GUID IND VAR BLOOD C; BARENBROCK M, 1993, CLIN NEPHROL, V40, P241; Berk PD, 1995, POLYCYTHEMIA VERA MY, P166; BERK PD, 1986, SEMIN HEMATOL, V23, P132; BERLIN NI, 1975, SEMIN HEMATOL, V12, P339; Bolan CD, 2001, TRANSFUSION, V41, P819, DOI 10.1046-j.1537-2995.2001.41060819.x; BORNSTEIN R, 1980, CAN J NEUROL SCI, V7, P293; Bouchair N, 2000, ARCH PEDIATRIE, V7, P249, DOI 10.1016-S0929-693X(00)88740-0; CAINELLI T, 1983, BRIT J DERMATOL, V108, P593, DOI 10.1111-j.1365-2133.1983.tb01062.x; CHETTY KG, 1990, CHEST, V98, P1073, DOI 10.1378-chest.98.5.1073; CHLUMSKY J, 1973, ACTA HEPATO-GASTRO, V20, P124; Cook Lynda S, 2010, J Infus Nurs, V33, P81, DOI 10.1097-NAN.0b013e3181d00010; Deacon AC, 2001, J CLIN PATHOL, V54, P500, DOI 10.1136-jcp.54.7.500; Desai TK, 2008, DIGEST DIS SCI, V53, P815, DOI 10.1007-s10620-007-9945-7; Dienstag JL, 2006, GASTROENTEROLOGY, V130, P225, DOI 10.1053-j.gastro.2005.11.011; Di Nisio M, 2007, BRIT J HAEMATOL, V136, P249, DOI 10.1111-j.1365-2141.2006.06430.x; DIPADOVA C, 1983, AM J MED SCI, V285, P2; Dwyer BE, 2009, MED HYPOTHESES, V72, P504, DOI 10.1016-j.mehy.2008.12.029; Elder GH, 1998, SEMIN LIVER DIS, V18, P67, DOI 10.1055-s-2007-1007142; Ellervik C, 2007, HEPATOLOGY, V46, P1071, DOI 10.1002-hep.21885; EPSTEIN JH, 1965, ARCH DERMATOL, V92, P286, DOI 10.1001-archderm.92.3.286; Estes J W, 1985, Med Herit, V1, P44; Falize L, 2006, HEPATOLOGY, V44, P472, DOI 10.1002-hep.21260; Fallah M, 2011, BRIT J HAEMATOL, V153, P283, DOI 10.1111-j.1365-2141.2010.08538.x; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038-ng0896-399; Franchini M, 2006, AM J HEMATOL, V81, P202, DOI 10.1002-ajh.20493; Fruchtman SM, 1997, SEMIN HEMATOL, V34, P17; Gisbert JP, 2003, J HEPATOL, V39, P620, DOI 10.1016-S0168-8278(03)00346-5; Gordeuk VR, 2003, BLOOD CELL MOL DIS, V31, P299, DOI 10.1016-S1079-9796(03)00164-5; Houschyar KS, 2012, BMC MED, V10, DOI 10.1186-1741-7015-10-54; HUMPHREY PRD, 1980, BRIT J HAEMATOL, V46, P435, DOI 10.1111-j.1365-2141.1980.tb05990.x; Lamy T, 1997, AM J MED, V102, P14, DOI 10.1016-S0002-9343(96)00351-8; Marchioli R, 2013, NEW ENGL J MED, V368, P22, DOI 10.1056-NEJMoa1208500; MARCHIOLI R, 2011, THROMBOSIS, V2011, P94240, DOI DOI 10.1155-2011-794240; McDonnell SM, 1999, AM J MED, V106, P619, DOI 10.1016-S0002-9343(99)00120-5; McLaren CE, 1998, GASTROENTEROLOGY, V114, P543, DOI 10.1016-S0016-5085(98)70538-4; McMullin MF, 2005, BRIT J HAEMATOL, V130, P174, DOI 10.1111-j.1365-2141.05535.x; MESSINEZY M, 1993, EUR J HAEMATOL, V51, P125; Montosi G, 2001, J CLIN INVEST, V108, P619, DOI 10.1172-JCI13468; Newman BH, 2003, TRANSFUSION, V43, P598, DOI 10.1046-j.1537-2995.2003.00368.x; Parapia LA, 2008, BRIT J HAEMATOL, V143, P490, DOI 10.1111-j.1365-2141.2008.07361.x; PEARSON TC, 1978, LANCET, V2, P1219; PEARSON TC, 1991, BLOOD REV, V5, P205, DOI 10.1016-0268-960X(91)90010-A; PICCIRILLO G, 1994, INT J CARDIOL, V44, P175, DOI 10.1016-0167-5273(94)90023-X; Pietrangelo A, 2006, GUT, V55, P564, DOI 10.1136-gut.2005.078063; RAMSAY CA, 1974, Q J MED, V43, P1; ROCCHI E, 1986, BRIT J DERMATOL, V114, P621, DOI 10.1111-j.1365-2133.1986.tb04071.x; ROCCHI E, 1986, J LAB CLIN MED, V107, P36; Roetto A, 2001, BLOOD, V97, P2555, DOI 10.1182-blood.V97.9.2555; Rombos Y, 2002, BLOOD CELL MOL DIS, V28, P283, DOI 10.1006-bcmd.2002.0489; Rombout-Sestrienkova E, 2012, TRANSFUSION, V52, P470, DOI 10.1111-j.1537-2995.2011.03292.x; Sanchez AM, 2001, JAMA-J AM MED ASSOC, V286, P1475, DOI 10.1001-jama.286.12.1475; Sartori M, 2011, EUR J GASTROEN HEPAT, V23, P1178, DOI 10.1097-MEG.0b013e328349923c; Schneeberg Norman G, 2002, Trans Stud Coll Physicians Phila, V24, P157; SHAH DM, 1980, SURGERY, V88, P686; Sheldon JH, 1935, HAEMOCHROMATOSIS, P164; Siah Chiang W, 2006, Clin Biochem Rev, V27, P5; Thiele J, 2008, WHO CLASSIFICATION T, P40; THOMAS DJ, 1977, LANCET, V2, P161; Tripathy Swagata, 2010, Lung India, V27, P24, DOI 10.4103-0970-2113.59264; Trousseau A, 1865, CLIN MED HOTEL PARIS, V2, P663; Van Genderen PJJ, 1997, SEMIN THROMB HEMOST, V23, P357, DOI 10.1055-s-2007-996109; Visapaa I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086-342773; Vlahakos DV, 2003, KIDNEY INT, V63, P1187, DOI 10.1046-j.1523-1755.2003.00850.x; von Recklinghausen FD, 1889, BERL KLIN WOCHENSCHR, V26, P925; Warnes CA, 2008, CIRCULATION, V118, pE714, DOI 10.1161-CIRCULATIONAHA.108.190690; Whitington PF, 2007, SEMIN LIVER DIS, V27, P243, DOI 10.1055-s-2007-985069; Zacharski LR, 2008, J NATL CANCER I, V100, P996, DOI 10.1093-jnci-djn2090
Recommended from our members
The human myeloproliferative disorders: molecular pathogenesis and clonal heterogeneity
No full textThe classical myeloproliferative disorders (MPD), comprising essential thrombocythaemia (ET), polycythaemia vera (PV) and idiopathic myelofibrosis (IMF), are clonal premalignant haematopoietic neoplasms associated with activating mutations in signalling pathway molecules and a variable tendency to develop acute myeloid leukaemia (AML). This thesis examined genotype-phenotype associations of JAK2 and MPL mutations, the presence of clonal diversity in the MPD and the genetic events associated with progressive disease.
Mutations in MPL were identified in 4% of ET and 7% of IMF but not in PV. Three different acquired MPL mutations were identified, one of which had been reported as an inherited allele. Although MPL mutations did not delineate a distinct clinical or histopathological subtype of ET, molecular testing provides an important new tool in the diagnostic armamentarium. Clones homozygous for the JAK2 V617F mutation were identified in female but not male patients with ET, suggesting that gender differences may be important in the determination of disease phenotype. In patients with two acquired genetic alterations, a signalling pathway mutation and a cytogenetic abnormality were usually present within the same clone. By contrast, coexistence of two signalling pathway mutations indicated the presence of biclonal disease that in two patients had arisen independently and not from a shared founder clone.
RAS mutations were identified as potential cooperating events in patients with JAK2 or MPL mutant IMF. In patients developing AML following a JAK2 V617F-positive MPD, those with V617F-positive leukaemia had progressed via an accelerated phase of disease and harboured acquired alterations of RUNX1 or EVI1. V617F-negative leukaemias tended to follow directly from ET or PV, and loss of the JAK2 mutation by reversion to wild-type due to mitotic recombination, gene deletion or gene conversion was excluded. The thesis concludes with a discussion of how clonal heterogeneity can be integrated into current models of MPD disease pathogenesis
